Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Reducing the immunogenicity of fusion proteins

Reducing the immunogenicity of fusion proteins

US Patent 8926973 · Granted Jan 6, 2015

Estimated economic value: $93,479,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modified urokinase-type plasminogen activator polypeptides and methods of use2025
Anti-PD-L1 antibodies2025
Metal oxides in lead-acid batteries2024
Complement factor I-related compositions and methods2024
Humanized and de-immunized antibodies2024
Anti-PD-L1 and IL-2 cytokines2024
Engineered microbe-targeting molecules and uses thereof2023
Modified urokinase-type plasminogen activator polypeptides and methods of use2023
Light chain immunoglobulin fusion proteins and methods of use thereof2022
TIGIT antibodies, encoding nucleic acids and methods of using said antibodies in2022
Engineered opsonin for pathogen detection and treatment2021
Engineered opsonin for pathogen detection and treatment2021